Clinical Trial Detail

NCT ID NCT02402036
Title A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Georgetown University
Indications

colorectal cancer

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.